ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Own Your Data, Accelerate Your Cure

  Move from passive donor to active innovator. Explore how patient communities are building their own research infrastructure and using AI to bypass traditional barriers to drug development.

• RWD For Early Clinical Development Planning And Strategy

  Delve into this use case where Citeline’s Real-World Data was used to inform clinical development strategy and differentiate target product profiles through patient journey mapping.

• Data Analytics For Better ClinRO Quality

  Many trials fail not because of ineffective treatments, but due to challenges in detecting treatment signals. Explore how advanced data analytics can improve ClinRO quality.

• Digital Measurement Of Nocturnal Scratch In Atopic Dermatitis

  A major challenge in managing atopic dermatitis (AD) is the lack of objective tools to measure the impact of nocturnal scratching, but new digital measurement solutions could address this gap.

• Simplify Your Clinical Data Flow To Streamline And Automate Modern Data Review

  Examine the three reasons why simplifying your clinical data flow can increase operational oversight, shorten data management cycle times, and reduce the manual burdens on data management teams.

• CRO Uses CRIO eSource To Double Monitoring Productivity

  Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.

• Unlock Historical Data To Enrich RBM Insights

  The data landscape for clinical operations is complex and comprised of many disparate sources, so a data agnostic solution is essential for full access and visibility into the data. Without an intuitive visual analytics tool, it becomes impossible to navigate data hierarchies and gain meaningful insights into the data.

• Real-World Evidence - Where Are We Now?

  Notwithstanding ongoing confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 years after the passage of the 21st Century Cures Act, the FDA continues to evaluate such data and evidence as it considers regulatory decisions.

• Strategies To Minimize Participant And Healthcare Provider Burden

  Patient-reported outcomes (PROs) are vital for clinical trials but can burden participants and providers. Discover strategies and practical solutions to ease these burdens and improve data quality.

• Webinar Recap: How EDC Can Support Modern Clinical Trials

  Gain insights from our recent webinar focused on the critical role EDC systems play in supporting modern working practices and innovative trial designs, structured around four key themes.